Tronox Holdings plc (TROX) Stock Price & Analysis
Tronox Holdings plc (TROX) closed at USD 3.48 on Thursday, October 22, 2026, up 6.75% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 3.26; the Oct 22, 2026 session ranged USD 3.2–3.48 on volume of 2,248,725 shares. Market capitalization is $555.76M, with a 52-week range of USD 2.86–10.59 (NYQ). Source: Nexqual, retrieved October 23, 2026 at 10:11 UTC.
Also available as compact Markdown for AI agents: nexqual.com/TROX.md
Key facts (TROX)
- Last four reported quarters (through Jun 30, 2026): revenue $3.06B, net income -$549M (-18.0% margin), free cash flow -$159M (SEC filings).
- Analysts: Hold (mean 3.38 on a 1–5 scale) (8 analysts), mean target USD 5.13 (range 4–8).
- Total return with dividends: 1Y -3.3% vs S&P 500 +14.9%; 5Y -83.5% vs S&P 500 +80.3%.
- Next earnings: 2026-11-04, EPS estimate USD -0.19, revenue estimate $851M.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (TROX)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $3.57B | $3.45B | $2.85B | $3.07B | $2.90B | $3.06B |
| Gross profit | $895M | $832M | $462M | $515M | $269M | — |
| Operating income | $577M | $458M | $186M | $219M | -$253M | -$219M |
| Net income | $286M | $497M | -$316M | -$48.0M | -$470M | -$549M |
| EPS (diluted) | $1.81 | $3.16 | -$2.02 | -$0.31 | -$2.97 | — |
| Free cash flow | $468M | $170M | -$77.0M | -$70.0M | -$281M | -$159M |
| Gross margin | 25.1% | 24.1% | 16.2% | 16.8% | 9.3% | — |
| Operating margin | 16.2% | 13.3% | 6.5% | 7.1% | -8.7% | -7.2% |
| Net margin | 8.0% | 14.4% | -11.1% | -1.6% | -16.2% | -18.0% |
| Revenue growth | +29.5% | -3.3% | -17.5% | +7.9% | -5.7% | — |
| Cash + short-term investments | $228M | $164M | $273M | $151M | $199M | — |
| Total debt | $2.61B | $2.52B | $2.84B | $2.83B | $3.20B | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (TROX)
P/S 0.2x · EV/EBITDA 63.4x · EV/Sales 1.2x · P/B 0.5x · FCF yield -28.61% · Earnings yield -98.78% · Dividend yield (paid, TTM) 7.92% · Net debt $3.00B · EV $3.55B
Analysts (TROX)
Consensus Hold (mean 3.38 on a 1–5 scale), 8 analysts; mean target USD 5.13 (low 4, high 8).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-20 | Truist Securities | Target lowered | Hold | $7 → $4 |
| 2026-10-12 | Goldman Sachs | Target lowered | Sell | $6.5 → $4 |
| 2026-10-05 | UBS | Target lowered | Neutral | $7 → $4.5 |
| 2026-09-30 | Mizuho | Target lowered | Underperform | $5.5 → $4.5 |
| 2026-08-13 | JP Morgan | Downgrade | Neutral → Underweight | $7 → $5 |
| 2026-07-22 | Goldman Sachs | Target lowered | Sell | $9 → $6.5 |
Total return (dividends reinvested) (TROX)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | -3.3% | -83.5% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | -3.4% | -30.2% |
| Volatility (annualized) | 74.0% | 62.3% |
| Max drawdown | -68.5% (May 2026→Oct 2026) | -85.9% (Oct 2021→Aug 2025) |
TROX analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Sep 2026) | $-0.19 | $-0.15 | +29.2% | $850.8M | 8 |
| Next quarter (ends Dec 2026) | $-0.23 | $-0.19 | +20.2% | $792.7M | 8 |
| Current fiscal year (ends Dec 2026) | $-1.47 | $-1.25 | +17.5% | $3.28B | 8 |
| Next fiscal year (ends Dec 2027) | $-0.45 | $-0.22 | +107.6% | $3.44B | 8 |
Key Statistics (as of October 23, 2026 at 10:11 UTC)
| Price | USD 3.48 |
|---|---|
| Change | ▲ 6.75% (up) |
| Previous Close | USD 3.26 |
| Open | USD 3.21 |
| Day Range | USD 3.2 – 3.48 |
| 52-Week Range | USD 2.86 – 10.59 |
| Volume | 2,248,725 shares |
| Market Cap | $555.76M |
| Exchange | NYQ |
Technical Analysis (TROX)
Nexqual's technical model rates TROX "STRONG SELL" based on 0 bullish and 5 bearish signals across 127 daily candles, as of October 23, 2026 at 10:11 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 34.31 (neutral) |
| vs SMA50 | Below (USD 4.46) |
| MACD | -0.31 (negative) |
Analyst Ratings (TROX)
Wall Street analysts rate TROX "Hold" based on 8 analysts, with a mean price target of USD 5.13 (range USD 4–8), per Nexqual as of October 23, 2026 at 10:11 UTC.
| Consensus Rating | Hold |
|---|---|
| Analyst Count | 8 |
| Mean Target | USD 5.13 |
| High Target | USD 8 |
| Low Target | USD 4 |
| Buy / Hold / Sell | 1 / 4 / 3 |
Earnings (TROX)
| Next Earnings Date | 2026-11-04 |
|---|---|
| EPS Estimate | USD -0.19 |
| Revenue Estimate | $850.78M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-06-30 | USD -0.51 vs est -0.37 ▼ miss |
| 2026-03-31 | USD -0.55 vs est -0.41 ▼ miss |
| 2025-12-31 | USD -0.6 vs est -0.58 ▼ miss |
| 2025-09-30 | USD -0.46 vs est -0.21 ▼ miss |
Source: Nexqual, October 23, 2026 at 10:11 UTC.
Financials & Fundamentals (TROX)
| Total Revenue | $3.06B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +18.70% |
| Gross Margin | +5.59% |
| Operating Margin | -1.96% |
| Profit Margin | -19.20% |
| ROE | -41.32% |
| Debt / Equity | 2.97 |
| Current Ratio | 2.55 |
| Total Cash | $214.00M |
| Total Debt | $3.54B |
| Free Cash Flow (last four quarters to Jun 2026, SEC 10-Q / 10-K) | -$159.00M (-5.2% of revenue) |
Source: Nexqual, October 23, 2026 at 10:11 UTC.
Financial Health Score (TROX)
Nexqual rates Tronox Holdings plc's overall financial health "Weak" across five dimensions, as of October 23, 2026 at 10:11 UTC.
| Growth | Weak — Revenue -6% YoY (annual), declining |
|---|---|
| Profitability | Critical — Gross margin 6%, operating -2% (last 12 months) |
| Balance Sheet | Weak — $194M cash and investments vs $3.19B debt (Jun 2026, SEC) |
| Cash Flow | Weak — FCF negative: -$159M (last 4 quarters to Jun 2026, SEC), burning cash |
| Efficiency | Critical — ROE -41%, ROA -1.2% |
Ownership (TROX)
| Insider Ownership | +25.54% |
|---|---|
| Institutional Ownership | +80.76% |
| Shares Outstanding | 159.70M |
| Float | 118.85M |
| Short % of Float | +15.61% |
Source: Nexqual, October 23, 2026 at 10:11 UTC.
Leadership (TROX)
Tronox Holdings plc is led by John D. Romano, CEO & Director, per Nexqual as of October 23, 2026 at 10:11 UTC.
| CEO & Director | John D. Romano |
|---|---|
| Senior VP & CFO | D. John Srivisal |
| Vice President of Strategy & Corporate Development | Eric Bender |
Major Backers & Investors (TROX)
Notable institutional backers of Tronox Holdings plc include Van Eck Associates Corporation, Primecap Management Company, Shaw D.E. & Co., Inc., according to Nexqual as of October 23, 2026 at 10:11 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Van Eck Associates Corporation | 5.05% |
| Primecap Management Company | 3.42% |
| Shaw D.E. & Co., Inc. | 3.17% |
| Charles Schwab Investment Management, Inc. | 3.07% |
| Point72 Asset Management, L.P. | 2.91% |
| VanEck ETF Trust-VanEck Rare Earth and Strategic Metals ETF | 2.77% |
| American Century Companies Inc | 2.52% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| BlackRock | 7.1% |
| Dimensional Fund Advisors | 4.17% |
| Vanguard Group | 3.31% |
Source: Nexqual, October 23, 2026 at 10:11 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BAK | Braskem SA | USD 1.6 | ▼ 2.44% |
| RYAM | Rayonier Advanced Materials Inc | USD 6.83 | ▼ 2.29% |
| LXU | LSB Industries, Inc. | USD 9.76 | ▼ 5.33% |
| ASIX | AdvanSix Inc. | USD 15.68 | ▲ 1.55% |
| WLKP | Westlake Chemical Partners LP | USD 20.96 | ▲ 0.43% |
| VHI | Valhi, Inc. | USD 14.33 | ▲ 2.58% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 10:11 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt